Di Maggio, R., Hsieh, M. M., Zhao, X., Calvaruso, G., Rigano, P., Renda, D., . . . Maggio, A. (2018). Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia. Int J Mol Sci.

Di Maggio, Rosario, Matthew M. Hsieh, Xiongce Zhao, Giuseppina Calvaruso, Paolo Rigano, Disma Renda, John F. Tisdale, und Aurelio Maggio. "Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients With Sickle-Beta Thalassemia." Int J Mol Sci 2018.

Di Maggio, Rosario, et al. "Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients With Sickle-Beta Thalassemia." Int J Mol Sci 2018.